Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ann-Christin Eder"'
Autor:
Ann-Christin Eder, Jessica Matthias, Martin Schäfer, Jana Schmidt, Nils Steinacker, Ulrike Bauder-Wüst, Lisa-Charlotte Domogalla, Mareike Roscher, Uwe Haberkorn, Matthias Eder, Klaus Kopka
Publikováno v:
Pharmaceuticals, Vol 15, Iss 3, p 267 (2022)
The development of PSMA-targeting low-molecular-weight hybrid molecules aims at advancing preoperative imaging and accurate intraoperative fluorescence guidance for improved diagnosis and therapy of prostate cancer. In hybrid probe design, the major
Externí odkaz:
https://doaj.org/article/8b4b66550ff94ab68f1d57c70b75cfe5
Autor:
Felix Kind, Ann-Christin Eder, Cordula A. Jilg, Philipp E. Hartrampf, Philipp T. Meyer, Juri Ruf, Kerstin Michalski
Publikováno v:
Journal of Nuclear Medicine. 64:605-610
Autor:
Ann-Christin Eder, Stefan W. Hell, Klaus Kopka, Matthias Eder, Uwe Haberkorn, Philipp T. Meyer, Ulrike Bauder-Wüst, Martin Schäfer, Johann Engelhardt, Jessica Matthias
STED LNCaP PSMA-STAR 600 LysoTracker Green DND-26 and STED LNCaP PSMA-STAR 600 SiR-lysosome 5um
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::401a6d67d86151bf4c5b4c4b2d1c53cc
https://doi.org/10.1158/0008-5472.22430310.v1
https://doi.org/10.1158/0008-5472.22430310.v1
Autor:
Ann-Christin Eder, Stefan W. Hell, Klaus Kopka, Matthias Eder, Uwe Haberkorn, Philipp T. Meyer, Ulrike Bauder-Wüst, Martin Schäfer, Johann Engelhardt, Jessica Matthias
Supplementary Methods Supplementary Figures Supplementary Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c61cc11358a8cc296599c766a99b959a
https://doi.org/10.1158/0008-5472.22430301
https://doi.org/10.1158/0008-5472.22430301
Autor:
Ann-Christin Eder, Stefan W. Hell, Klaus Kopka, Matthias Eder, Uwe Haberkorn, Philipp T. Meyer, Ulrike Bauder-Wüst, Martin Schäfer, Johann Engelhardt, Jessica Matthias
Targeted imaging and therapy approaches based on novel prostate-specific membrane antigen (PSMA) inhibitors have fundamentally changed the treatment regimen of prostate cancer. However, the exact mechanism of PSMA inhibitor internalization has not ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fb254899b8c5300ca67b4619a85d563
https://doi.org/10.1158/0008-5472.c.6513591.v1
https://doi.org/10.1158/0008-5472.c.6513591.v1
Autor:
Ann-Christin Eder, Matthias Eder
Publikováno v:
Der Onkologe. 28:126-134
Autor:
Jana Schmidt, Mareike Roscher, Matthias Eder, Ann-Christin Eder, Klaus Kopka, Karin Leotta, Martin Schäfer, Uwe Haberkorn, Ulrike Bauder-Wüst
Publikováno v:
J Nucl Med
The evolution of peptidomimetic hybrid molecules for preoperative imaging and guided surgery targeting the prostate-specific membrane antigen (PSMA) significantly progressed over the past few years, and some approaches are currently being evaluated f
Autor:
Ann-Christin Eder, Philipp T. Meyer, Matthias Eder, Martin Schäfer, Ulrike Bauder-Wüst, Klaus Kopka, Johann Engelhardt, Uwe Haberkorn, Stefan W. Hell, Jessica Matthias
Publikováno v:
Cancer Research. 81:2234-2245
Targeted imaging and therapy approaches based on novel prostate-specific membrane antigen (PSMA) inhibitors have fundamentally changed the treatment regimen of prostate cancer. However, the exact mechanism of PSMA inhibitor internalization has not ye
Publikováno v:
Cancers, Vol 13, Iss 3967, p 3967 (2021)
Cancers
Cancers
Simple Summary One of the most frequently diagnosed cancer in men is adenocarcinoma of the prostate. Once the disease is metastatic, only very limited treatment options are available, resulting in a very short median survival time of 13 months; howev
Autor:
Christian Poulie, Mohamed El Fakiri, Nawal Ayada, Teodor Gamzov, Marius Müller, Holger Jensen, Sture Lindegren, Andreas Jensen, Andreas Kjær, Ann-Christin Eder, Matthias Eder, Matthias Herth
Publikováno v:
Nuclear Medicine and Biology. :S60